MAPT and Alzheimer disease: Irreversible loss of taxol-stimulated tubulin polymerization was demonstrated in samples from patients with late-onset Alzheimer’s disease, patients with PSEN2 and FTDP-17 mutations, while it did not occur in subjects with mild cognitive impairment or controls.